These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22127772)

  • 1. New image for the drug industry.
    Cohen D
    BMJ; 2011 Nov; 343():d7713. PubMed ID: 22127772
    [No Abstract]   [Full Text] [Related]  

  • 2. Big pharma under the spotlight.
    Farham B
    S Afr Med J; 2013 May; 103(6):352. PubMed ID: 23725968
    [No Abstract]   [Full Text] [Related]  

  • 3. Andrew Witty: the acceptable face of big pharma? Interviewed by Rebecca Coombes.
    Witty A
    BMJ; 2013 Mar; 346():f1458. PubMed ID: 23468295
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmaceutical sciences in 2020.
    Crommelin D; Stolk P; Besançon L; Shah V; Midha K; Leufkens H
    Nat Rev Drug Discov; 2010 Feb; 9(2):99-100. PubMed ID: 20118959
    [No Abstract]   [Full Text] [Related]  

  • 5. Joint working. A dose of partnership.
    Moore A
    Health Serv J; 2012 Nov; 122(6329):Suppl 6-7. PubMed ID: 23488347
    [No Abstract]   [Full Text] [Related]  

  • 6. Into the valley of death: research to innovation.
    Hudson J; Khazragui HF
    Drug Discov Today; 2013 Jul; 18(13-14):610-3. PubMed ID: 23402848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competition: Unlikely partnerships.
    Savage N
    Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391
    [No Abstract]   [Full Text] [Related]  

  • 8. Risky business.
    Ment Health Today; 2005 May; ():12-3. PubMed ID: 15938578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cohorts and registers: Which public/private partnerships to choose?].
    Jouan-Flahault C; Landais P; Thomas R; Parker S; Genevaz D
    Presse Med; 2012 May; 41 Suppl 1():S15-9. PubMed ID: 22464892
    [No Abstract]   [Full Text] [Related]  

  • 10. Global health. Public-private partnerships proliferate.
    Cohen J
    Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
    [No Abstract]   [Full Text] [Related]  

  • 11. Public-private partnerships in drug development for underdeveloped countries: an interview with Craig Wheeler, President of Chiron's Biopharmaceutical Division. Interview by Thomasine Kushner.
    Wheeler C
    Camb Q Healthc Ethics; 2003; 12(4):429-33. PubMed ID: 14619375
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatry has effectively become a commodity that is being sold to the drug industry.
    Timimi S
    Ment Health Today; 2005 Jun; ():21. PubMed ID: 15999409
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving R&D productivity of pharmaceutical companies through public-private partnership: experiences from the Innovative Medicines Initiative.
    Laverty H; Gunn M; Goldman M
    Expert Rev Pharmacoecon Outcomes Res; 2012 Oct; 12(5):545-8. PubMed ID: 23136843
    [No Abstract]   [Full Text] [Related]  

  • 14. Lost opportunities.
    Phan P; Wong D
    Nature; 2017 Dec; 552(7683):S18. PubMed ID: 29220004
    [No Abstract]   [Full Text] [Related]  

  • 15. VTE: From partnership to prevention.
    Savage S
    Health Serv J; 2012 Apr; 122(6301):26-7. PubMed ID: 22666994
    [No Abstract]   [Full Text] [Related]  

  • 16. Restoring confidence in the pharmaceutical industry.
    Bauchner H; Fontanarosa PB
    JAMA; 2013 Feb; 309(6):607-9. PubMed ID: 23403686
    [No Abstract]   [Full Text] [Related]  

  • 17. Health and wealth are partners.
    Barker R; Smith S
    Health Serv J; 2010 May; 120(6206):14-5. PubMed ID: 20540189
    [No Abstract]   [Full Text] [Related]  

  • 18. Public-private health partnerships: a strategy for WHO.
    Buse K; Waxman A
    Bull World Health Organ; 2001; 79(8):748-54. PubMed ID: 11545332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allocation of control rights and cooperation efficiency in public-private partnerships: theory and evidence from the Chinese pharmaceutical industry.
    Zhang Z; Jia M; Wan D
    Int J Health Care Finance Econ; 2009 Jun; 9(2):169-82. PubMed ID: 19360467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical industry guide. Strange bedfellows?
    Moore A
    Health Serv J; 2002 Nov; 112(5833):suppl 13-5. PubMed ID: 12478712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.